About MedAlliance
MedAlliance is a company based in Nyon (Switzerland) founded in 2008 was acquired by Cordis in October 2023. MedAlliance operates in a competitive market with competitors including Nectero Medical, Mercator MedSystems, PharmaIN, VESTECK and Advanced NanoTherapies, among others.
- Headquarter Nyon, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of MedAlliance
Unlock access to complete
Unlock access to complete
Funding Insights of MedAlliance
Detailed funding history for MedAlliance
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in MedAlliance
MedAlliance has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cordis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cardiovascular and endovascular devices are developed and marketed by Cordis.
|
Locked | Locked | Locked |
Investor details for MedAlliance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedAlliance
Investment portfolio details for MedAlliance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedAlliance
Detailed financials for MedAlliance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medalliance Comparisons
Peer comparison for MedAlliance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedAlliance
MedAlliance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nectero Medical, Mercator MedSystems, PharmaIN, VESTECK and Advanced NanoTherapies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An endovascular device for treating abdominal aortic aneurysms is developed.
|
|
| Locked | Locked | Locked |
Catheter-guided microfluid injection systems are developed for targeted tissue therapies.
|
|
| Locked | Locked | Locked |
Proprietary drug delivery platforms are developed for API enhancement.
|
|
| Locked | Locked | Locked |
Developer of a device for the treatment of aortic aneurysms
|
|
| Locked | Locked | Locked |
Developer of a drug delivery device for cardiac vascular diseases
|
|
| Locked | Locked | Locked |
Transdermal drug patches and wound closure devices are developed.
|
Detailed competitors of MedAlliance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medalliance
Complete news archive for MedAlliance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedAlliance
MedAlliance was founded in 2008.
MedAlliance is headquartered in Nyon, Switzerland. It is registered at Nyon, Vaud, Switzerland.
Jeffrey B. Jump is the current CEO of MedAlliance.
MedAlliance was founded in 2008 in Nyon, Switzerland, within the medical device sector. Focus is placed on developing drug delivery technologies for coronary and peripheral artery diseases. A sustained limus release drug-eluting balloon catheter has been engineered to treat both conditions. Anti-proliferative and anti-inflammatory effects are improved through this approach, with reduced cellular damage and accelerated vessel healing observed in operations.
MedAlliance's top competitors include Mercator MedSystems, PharmaIN and Advanced NanoTherapies.
MedAlliance has 1 investor. Key investors include Cordis.